Tricalcium Phosphate and Chitosan as Bone Regenerator Versus Autologous Graft in Surgery for Mandibular Fracture
Therapeutic Efficacy of Tricalcium Phosphate and Chitosan as Bone Regenerator Versus Autologous Graft in Surgery for Mandibular Fracture
1 other identifier
interventional
24
1 country
1
Brief Summary
Introduction After a mandibular fracture where bone has been lost, a number of complications and challenges are presented in trying to solve them. These defects are mainly classified into two groups: functional and cosmetic. The functional defects are incompetence of the lower lip, salivary incontinence, severe difficulty chewing and swallowing, temporomandibular joint disorders and difficulty in pronouncing words. Esthetically facial asymmetry is produced with collapse of the affected side. Unreconstructed jaw retrusion and tends to offset the affected side, there is a change in mandibular movements, which, previous vertical movements are replaced by oblique or diagonal movements controlled by a single temporomandibular joint. It also presents a limitation in motility and lingual force, besides proprioception disorder left by the inferior alveolar nerve The loss of bone in mandibular fractures, is one of the great challenges facing maxillofacial surgery and unfortunately increasingly common. That's why they have done and are still doing research for the development of biomaterials, all with the purpose of trying to solve this problem by offering the patient better results than those obtained in the past, restoring both function and facial aesthetics according to each case
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jan 2014
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 31, 2014
CompletedFirst Posted
Study publicly available on registry
March 7, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedOctober 3, 2023
September 1, 2023
1 year
January 31, 2014
September 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Bone density determination in regenerated bone.
Determined with computed tomography measure by using Hounsfield Units.
30 days after the procedure.
Bone density determination in regenerated bone.
Determined with computed tomography measure by using Hounsfield Units.
6 months after the procedure.
Secondary Outcomes (11)
Classification of mandibular fracture
One day before surgery
Edema
Patients will be followed daily from the immediate postoperative period until discharge, an expected average of 3 days.
Postoperative infection.
Patients will be followed daily from the immediate postoperative period until discharge, an expected average of 3 days.
Defect Size
30 days after the procedure.
Edema
8 days after procedure.
- +6 more secondary outcomes
Other Outcomes (2)
Age
One day before surgery
Gender
One day before surgery
Study Arms (2)
Tricalcium Phosphate / Chitosan
EXPERIMENTALAutologous Graft
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Patients ot the service of reconstructive and plastic surgery of the Civil Hospital in Guadalajara Fray Antonio Mayor, with a diagnosis of traumatic mandibular fracture with bone defect \< 2.5 cm.
- Wishing to participate in the study
You may not qualify if:
- Patients who have undergone radiation therapy.
- Psychiatric Patients.
- Patients who have not signed informed consent.
- Patients with Diabetes
- Patients with alterations in bone metabolism
- Patients with kidney diseases
- Patients who receipt corticosteroids
- Patients with heart disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Civil Hospital of Guadalajara Fray Antonio Alcalde
Guadalajara, Jalisco, 44280, Mexico
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alejandro Gonzalez-Ojeda, PhD
Instituto Mexicano del Seguro Social
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
January 31, 2014
First Posted
March 7, 2014
Study Start
January 1, 2014
Primary Completion
January 1, 2015
Study Completion
January 1, 2017
Last Updated
October 3, 2023
Record last verified: 2023-09